Targeting of Lipid-Protamine-DNA (LPD) Lipopolyplexes Using RGD Motifs

References

• Gao X, Huang L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 1996; 35: 1027–1036
   PubMed Web of Science ®Google Scholar
• Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 1997; 4: 891–900
   PubMed Web of Science ®Google Scholar
• Li S, Rizzo MA, Bhattacharya S, Huang L. Characterization of cationic lipidprotamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther 1998; 5(7)930–937
   PubMed Web of Science ®Google Scholar
• Li S, Tseng W-C, Beer Stolz D, Wu S-P, Watkins SC, Huang L. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther 1999; 6: 585–594
   PubMed Web of Science ®Google Scholar
• Harvie P, Wong FM, Bally MB. Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation. Biophys J 1998; 75(2)1040–1051
   PubMed Web of Science ®Google Scholar
• Zelphati O, Szoka FC, Jr. Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci USA 1996; 593: 11493–11498
   Google Scholar
• Xu Y, Szoka FC, Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996; 35(18)5616–5623
   PubMed Web of Science ®Google Scholar
• Liu Y, Mounkes LC, Liggitt HD, Brown CS, Solodin I, Heath TD, Debs RJ. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotech 1997; 15(2)167–173
   PubMed Web of Science ®Google Scholar
• Zhu N, Liggitt D, Liu Y, Debs R. Systematic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209–211
   PubMed Web of Science ®Google Scholar
• Lasic DD. Novel applications of liposomes. Trends in Biotech 1998; 16(7)307–321
   PubMed Web of Science ®Google Scholar
• Needham D, Stoicheva N, Zhelev DV. Exchange of monooleoylphosphatidylcholine as monomer and micelle with membranes containing poly(ethylene glycol)lipid. Biophys J 1997; 73(5)2615–2629
   PubMedGoogle Scholar
• Anwer K, Kao G, Proctor B, Rolland A, Sullivan S. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions. J Drug Targeting 2000; 8(2)125–135
   PubMed Web of Science ®Google Scholar
• Harvie P, Wong FM, Bally MB. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J Pharm Sci 2000; 89(5)652–663
   PubMed Web of Science ®Google Scholar
• Mok KWC, Lam AMI, Cullis PR. Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties. Biochim et Biophys Acta 1999; 1419(2)137–150
   PubMed Web of Science ®Google Scholar
• Zhang YP, Sekirov L, Saravolac EG, Wheeler JJ, Tardi P, Clow K, Leng E, Sun R, Cullis PR, Scherrer P. Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties. Gene Ther 1999; 6(8)1438–1447
   PubMed Web of Science ®Google Scholar
• Kirpotin D, Hong K, Mullah N, Papahadjopoulos D, Zalipsky S. Liposomes with detachable polymer coating: destabilization fusion of dioleoylphosphattidylethanolamine vesicles triggered by cleavage of surfacegrafted poly(ethylene glycol). FEBS Lett 1997; 388: 115–118
   Google Scholar
• Kichler A, Frish B, Lima de Souza D, Schuber F. Receptor-mediated gene delivery with nonviral DNA carriers. J Lipo Res 2000; 10(4)443–460
   Google Scholar
• Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998; 279(5349)377–380
   PubMed Web of Science ®Google Scholar
• Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nature Biotech 1997; 15(6)542–546
   PubMed Web of Science ®Google Scholar
• Fortunati E, Ehlert E, van Loo ND, Wyman C, Eble JA, Grosveld F, Scholte BJ. A multi-domain protein for betal integrin-targeted DNA delivery. Gene Ther 2000; 7(17)1505–1515
   PubMedGoogle Scholar
• Aoki Y, Hosaka S, Kawa S, Kiyosawa K. Potential tumor-targeting peptide vector of histidylated oligolysine conjugated to a tumor-homing RGD motif. Cancer Gene Ther 2001; 8(10)783–787
   PubMedGoogle Scholar
• Muller K, Nahde T, Fahr A, Muller R, Brusselbach S. Highly efficient transduction of endothelial cells by targeted artificial virus-like particles. Cancer Gene Ther 2001; 8(2)107–117
   PubMed Web of Science ®Google Scholar
• Scott ES, Wiseman JW, Evans MJ, Colledge WH. Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J Gene Med 2001; 3(2)125–134
   PubMedGoogle Scholar
• Uduehi N, Moss SH, Nutatall J, Pouton C. Cationic lipid-mediated transfection of differentiated Caco-2 cells: a filter culture model of gene delivery to a polarized epithelium. Pharm Res 1999; 16: 1805–1811
   PubMed Web of Science ®Google Scholar
• Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cheresh DA. Tumor regression by targeted gene delivery to the neovasculature. Science 2002; 296(5577)2404–2407
   PubMed Web of Science ®Google Scholar
• Shi W, Arnold GS, Bartlett JS. Insertional mutagenesis of the adeno-associated virus type 2 (aav2) capsid gene and generation of aav2 vectors targeted to alternative cell-surface receptors. Hum Gene Ther 2001; 12(14)1697–1711
   PubMed Web of Science ®Google Scholar
• Grill J, Van Beusechem VW, Van Der Valk P, Dirven CM, Leonhart A, Pherai DS, Haisma HJ, Pinedo HM, Curiel DT, Gerritsen WR. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids. Clin Cancer Res 2001; 7(3)641–650
   PubMed Web of Science ®Google Scholar
• Pool GL, French ME, Edwards RA, Huang L, Lumb RH. Use of radiolabeled hexadecyl cholesteryl ether as a liposome marker. Lipids 1982; 17(6)448–452
   PubMedGoogle Scholar
• Mounkes LC, Zhong W, Ciprespalacin G, Heath TD, Debs RJ. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J of Bio Chem 1998; 273(40)26164–26170
   PubMedGoogle Scholar
• Maruyama K, Ishida O, Takizawa T, Moribe K. Possibility of active targeting to tumor tissues with liposomes. Adv Drugn Del Rev 1999; 40: 89–102
   PubMed Web of Science ®Google Scholar
• Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 1998; 95(8)4607–4612
   PubMed Web of Science ®Google Scholar
• Li WM, Xue L, Mayer LD, Bally MB. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surfaceassociated binding ligands on liposomes. Biochim Biophys Acta 2001; 1513(2)193–206
   PubMedGoogle Scholar